Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1994 1
1996 2
1997 1
1998 1
1999 2
2001 2
2002 2
2003 3
2004 1
2005 3
2008 3
2009 8
2010 3
2011 3
2012 5
2013 4
2014 7
2015 3
2016 5
2017 3
2018 2
2019 4
2020 1
2021 6
2022 3
2023 5
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
Herrera AF, LeBlanc M, Castellino SM, Li H, Rutherford SC, Evens AM, Davison K, Punnett A, Parsons SK, Ahmed S, Casulo C, Bartlett NL, Tuscano JM, Mei MG, Hess BT, Jacobs R, Saeed H, Torka P, Hu B, Moskowitz C, Kaur S, Goyal G, Forlenza C, Doan A, Lamble A, Kumar P, Chowdhury S, Brinker B, Sharma N, Singh A, Blum KA, Perry AM, Kovach AE, Hodgson D, Constine LS, Shields LK, Prica A, Dillon H, Little RF, Shipp MA, Crump M, Kahl B, Leonard JP, Smith SM, Song JY, Kelly KM, Friedberg JW. Herrera AF, et al. Among authors: tuscano jm. N Engl J Med. 2024 Oct 17;391(15):1379-1389. doi: 10.1056/NEJMoa2405888. N Engl J Med. 2024. PMID: 39413375 Free PMC article. Clinical Trial.
Checkpoint inhibition in hematologic malignancies.
Tsumura A, Levis D, Tuscano JM. Tsumura A, et al. Among authors: tuscano jm. Front Oncol. 2023 Oct 17;13:1288172. doi: 10.3389/fonc.2023.1288172. eCollection 2023. Front Oncol. 2023. PMID: 37920162 Free PMC article. Review.
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.
Chavez JC, Foss FM, William BM, Brammer JE, Smith SM, Prica A, Zain JM, Tuscano JM, Shah H, Mehta-Shah N, Geethakumari PR, Wang BX, Zantinge S, Wang L, Zhang L, Boutrin A, Zhao W, Cheng L, Standifer N, Hewitt L, Enowtambong E, Shao W, Sharma S, Carlesso G, Moscow JA, Siu LL. Chavez JC, et al. Among authors: tuscano jm. Clin Cancer Res. 2023 May 15;29(10):1869-1878. doi: 10.1158/1078-0432.CCR-22-2955. Clin Cancer Res. 2023. PMID: 36826995 Free PMC article.
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.
Rutherford SC, Li H, Herrera AF, LeBlanc M, Ahmed S, Davison K, Parsons SK, Unger JM, Perry AM, Casulo C, Bartlett NL, Tuscano JM, Hess BT, Torka P, Kumar P, Jacobs R, Song JY, Castellino SM, Kahl B, Leonard JP, Smith SM, Friedberg JW, Evens AM. Rutherford SC, et al. Among authors: tuscano jm. J Clin Oncol. 2025 Sep 20;43(27):2968-2973. doi: 10.1200/JCO-25-00204. Epub 2025 Jun 16. J Clin Oncol. 2025. PMID: 40523203 Clinical Trial.
A microbiome assessment of medical marijuana.
Thompson GR 3rd, Tuscano JM, Dennis M, Singapuri A, Libertini S, Gaudino R, Torres A, Delisle JM, Gillece JD, Schupp JM, Engelthaler DM. Thompson GR 3rd, et al. Among authors: tuscano jm. Clin Microbiol Infect. 2017 Apr;23(4):269-270. doi: 10.1016/j.cmi.2016.12.001. Epub 2016 Dec 9. Clin Microbiol Infect. 2017. PMID: 27956269 Free article. No abstract available.
Adverse health effects of marijuana use.
Thompson GR 3rd, Tuscano JM. Thompson GR 3rd, et al. Among authors: tuscano jm. N Engl J Med. 2014 Aug 28;371(9):878-9. doi: 10.1056/NEJMc1407928. N Engl J Med. 2014. PMID: 25162901 No abstract available.
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503).
Jonas BA, Fisch SC, Curtin PT, Schiller GJ, Jeyakumar D, Tzachanis D, Bejar R, Qi L, Wieduwilt MJ, Tuscano JM, Damon L, Logan AC; University of California Hematologic Malignancies Consortium. Jonas BA, et al. Among authors: tuscano jm. Leuk Res. 2025 Aug;155:107717. doi: 10.1016/j.leukres.2025.107717. Epub 2025 Jun 2. Leuk Res. 2025. PMID: 40479857 Clinical Trial.
82 results